Zobrazeno 1 - 10
of 46
pro vyhledávání: '"BT Slingsby"'
Autor:
BT Slingsby, Kiyoshi Kurokawa
Publikováno v:
The Lancet Global Health, Vol 1, Iss 4, Pp e184-e185 (2013)
Externí odkaz:
https://doaj.org/article/bd57b2ff470b4c1a8bfad8622212170c
Publikováno v:
Journal of the American College of Cardiology. 81:306
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::744ea6998679660fbe9070036de35ebb
https://doi.org/10.1016/s0735-1097(23)00750-7
https://doi.org/10.1016/s0735-1097(23)00750-7
Autor:
Aya Fujii, Yuki Hiraga, Mizue Kawai, Kei Ogawa, Yoshiyasu Ohta, Sheikh Mohammed Ashfaq Rahman, Hidetoshi Shimizu, Kanami Sugimoto-Kawabata, Mattheus (Thijs) Van Iersel, Jan Jaap Van Lier, BT Slingsby, David Rodman
Publikováno v:
Journal of the American College of Cardiology. 81:616
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::105a47a6a633786f214c48cf9f9a93d0
https://doi.org/10.1016/s0735-1097(23)01060-4
https://doi.org/10.1016/s0735-1097(23)01060-4
Autor:
S Horii, K Shioda, H Hashimoto, Y Murakami, Keizo Takemi, S Mabuchi, I Takizawa, LO Gostin, N Akahane, S Maruyama, C Miyoshi, Y Maeda, T Inokuchi, Y Sasabuchi, S Hara, A Watabe, K Katsuno, K Shiba, C Sato, Satoshi Ezoe, Shuhei Nomura, Makiko Matsuo, M Machida, A Sorita, H Nishimoto, S Kasahara, T Ono, K Yasuda, BT Slingsby, N Kondo, Hideo Yasunaga, S Kanamori, Jessica Kraus, Yasushi Katsuma, K Tase, H Okayasu, Hidechika Akashi, T Kumakawa, Gavin Yamey, H Murakami, Marco Schäferhoff, EM Suzuki, T Izutsu, J Kemp, Tadayuki Tanimura, Sarah Krull Abe, Stuart Gilmour, Kenji Shibuya, R Hayashi, K Taneda, Amina Sugimoto, Y Hara, Amanda E. Smith, T Kato, M Ozawa, Yohsuke Takasaki, Reich, B Tamamura, Hideaki Shiroyama, T Sugishita, Takashi Oshio, S Okada, Y Yoneyama
Publikováno v:
The Lancet. 387:2155-2162
In today's highly globalised world, protecting human security is a core challenge for political leaders who are simultaneously dealing with terrorism, refugee and migration crises, disease epidemics, and climate change. Promoting universal health cov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3af4695a67698d436bfc7a5821f24b21
https://doi.org/10.1016/s0140-6736(16)30177-5
https://doi.org/10.1016/s0140-6736(16)30177-5
Autor:
Shaden Kamhawi, Bernhard Fleischer, Kathryn M. Jones, Bin Zhan, Maria Elena Bottazzi, Jaime Ortega, Roberto Tapia-Conyer, Bruce Y. Lee, Peter J. Hotez, Miguel Betancourt Cravioto, Kristina M. Bacon, Samuel Ponce de Leon Rosales, Michael J. Heffernan, Eric Dumonteil, BT Slingsby, Jesus G. Valenzuela
Publikováno v:
Expert Review of Vaccines. 11:1043-1055
Chagas disease is a leading cause of heart disease affecting approximately 10 million people in Latin America and elsewhere worldwide. The two major drugs available for the treatment of Chagas disease have limited efficacy in Trypanosoma cruzi-infect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89aeff15a3182b60de1c3117af0dd4ff
https://doi.org/10.1586/erv.12.85
https://doi.org/10.1586/erv.12.85
Autor:
BT Slingsby, Kiyoshi Kurokawa
Publikováno v:
The Lancet Global Health, Vol 1, Iss 4, Pp e184-e185 (2013)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e154d44491fba75484cedf67823dc70
https://pubmed.ncbi.nlm.nih.gov/25104343
https://pubmed.ncbi.nlm.nih.gov/25104343
Autor:
Shimizu H; Clinical Pharmacology Group, Data Science Department, Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan., Tortorici MA; Mineralys Therapeutics, Radnor, Pennsylvania, USA., Ohta Y; Clinical Research & Development II, Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan., Ogawa K; Clinical Pharmacology Group, Data Science Department, Ikuyaku, Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan., Rahman SMA; Clinical Department, Mitsubishi Tanabe Pharma Corporation, London, UK., Fujii A; Research Unit/Neuroscience, Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Kanagawa, Japan., Hiraga Y; Translational Research, Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan., Kawai M; Research Unit/Immunology & Inflammation, Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharm Corporation, Kanagawa, Japan., Sugimoto-Kawabata K; Sohyaku Strategy & Planning Department, Sohyaku, Innovative Research Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan., van Iersel MT; ICON, Groningen, The Netherlands., van Lier JJ; ICON, Groningen, The Netherlands., Djedjos S; Mineralys Therapeutics, Radnor, Pennsylvania, USA., Slingsby BT; Mineralys Therapeutics, Radnor, Pennsylvania, USA., Rodman DM; Mineralys Therapeutics, Radnor, Pennsylvania, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70000.
Autor:
Laffin LJ; Cleveland Clinic Foundation, Cleveland, Ohio.; C5 Research, Cleveland Clinic Foundation, Cleveland, Ohio., Rodman D; Mineralys Therapeutics, Radnor, Pennsylvania., Luther JM; Vanderbilt University Medical Center, Nashville, Tennessee., Vaidya A; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Weir MR; University of Maryland School of Medicine, Baltimore., Rajicic N; Cytel, Cambridge, Massachusetts., Slingsby BT; Mineralys Therapeutics, Radnor, Pennsylvania., Nissen SE; Cleveland Clinic Foundation, Cleveland, Ohio.; C5 Research, Cleveland Clinic Foundation, Cleveland, Ohio.
Publikováno v:
JAMA [JAMA] 2023 Sep 26; Vol. 330 (12), pp. 1140-1150.
Autor:
Katsuno K; Global Health Innovative Technology (GHIT) Fund, Ark Hills, Sengokuyama Mori Tower (25F), 1-9-10 Roppongi, Minato-ku, Tokyo 106-0032, Japan., Burrows JN; Medicines for Malaria Venture (MMV), 20, Route de Pré-Bois, 1215 Geneva 15, Switzerland., Duncan K; Bill &Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA., Hooft van Huijsduijnen R; Medicines for Malaria Venture (MMV), 20, Route de Pré-Bois, 1215 Geneva 15, Switzerland., Kaneko T; Global Alliance for TB Drug Development (TB Alliance), 40 Wall Street, 24th Floor, New York, New York 10005, USA., Kita K; University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo 113-0033, Japan., Mowbray CE; Drugs for Neglected Diseases initiative (DNDi), 15 Chemin Louis-Dunant, 1202 Geneva, Switzerland., Schmatz D; Medicines for Malaria Venture (MMV), 20, Route de Pré-Bois, 1215 Geneva 15, Switzerland., Warner P; Bill &Melinda Gates Foundation, PO Box 23350, Seattle, Washington 98102, USA., Slingsby BT; Global Health Innovative Technology (GHIT) Fund, Ark Hills, Sengokuyama Mori Tower (25F), 1-9-10 Roppongi, Minato-ku, Tokyo 106-0032, Japan.
Publikováno v:
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2015 Nov; Vol. 14 (11), pp. 751-8. Date of Electronic Publication: 2015 Oct 05.